{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Sham+Treatment&page=10", "query": { "intervention": "Intervention 2 - Sham Treatment", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 1787, "total_pages": 179, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Sham+Treatment&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Sham+Treatment&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T06:35:09.342Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05986292", "title": "A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee", "Diabetic Neuropathic Pain", "Chronic Low-back Pain" ], "interventions": [ { "name": "LY3016859 ISA", "type": "DRUG" }, { "name": "LY3556050 ISA", "type": "DRUG" }, { "name": "LY3526318 ISA", "type": "DRUG" }, { "name": "LY3857210 ISA", "type": "DRUG" }, { "name": "Placebo Oral", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "LY4065967 ISA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10000, "start_date": "2020-01-30", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 52 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05986292" }, { "nct_id": "NCT05826912", "title": "Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Atorvastatin Calcium", "type": "DRUG" }, { "name": "Minocycline Hydrochloride", "type": "DRUG" }, { "name": "Candesartan Cilexetil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 672, "start_date": "2024-08-01", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2025-12-22", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 18, "location_summary": "San Francisco, California • Indianapolis, Indiana • Lexington, Kentucky + 14 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05826912" }, { "nct_id": "NCT05545319", "title": "A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "Coronavirus Disease 2019 (COVID-19)", "Immunocompromised", "Hospitalization", "Child, Hospitalized" ], "interventions": [ { "name": "Nirmatrelvir", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Placebo for nirmatrelvir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 0, "start_date": "2022-12-13", "completion_date": "2024-01-06", "has_results": false, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 2, "location_summary": "Cooperstown, New York • New York, New York", "locations": [ { "city": "Cooperstown", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05545319" }, { "nct_id": "NCT03861767", "title": "REMAP Trial for Optimizing Surgical Outcomes at UPMC", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Aging" ], "interventions": [ { "name": "Metformin ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matthew Neal MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 302, "start_date": "2019-04-15", "completion_date": "2022-09-23", "has_results": true, "last_update_posted_date": "2024-06-18", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03861767" }, { "nct_id": "NCT03283930", "title": "A Clinical Trial of a Gamified Attention Bias Modification Training in Anxious Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety Disorders" ], "interventions": [ { "name": "Active Attention Bias Modification Training", "type": "BEHAVIORAL" }, { "name": "Placebo Attention Bias Modification Training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "8 Years to 17 Years" }, "enrollment_count": 121, "start_date": "2016-11-01", "completion_date": "2023-09-01", "has_results": true, "last_update_posted_date": "2024-04-09", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03283930" }, { "nct_id": "NCT07792395", "title": "Ginger's Therapeutic Potential in Asthma", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Ginger Extract", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emily DiMango, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2026-11", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07792395" }, { "nct_id": "NCT07892664", "title": "Reducing Arterial Inflammation Using Eplerenone and Statins in HIV", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "HIV (Human Immunodeficiency Virus)", "Cardiovascular Diseases (CVD)", "Arterial Inflammation", "Heart Disease" ], "interventions": [ { "name": "Eplerenone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 124, "start_date": "2027-03-01", "completion_date": "2031-05-31", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 2, "location_summary": "Los Angeles, California • Boston, Massachusetts", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07892664" }, { "nct_id": "NCT07779967", "title": "Alcohol, Breast Cancer, and Metabolism", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alcohol Drinking", "Ethanol Intoxication", "Breastfeeding" ], "interventions": [ { "name": "Low-alcohol level exposure", "type": "OTHER" }, { "name": "Breast-pumping time", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Illinois at Urbana-Champaign", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "21 Years to 45 Years · Female only" }, "enrollment_count": 50, "start_date": "2026-09-03", "completion_date": "2032-03-01", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 1, "location_summary": "Urbana, Illinois", "locations": [ { "city": "Urbana", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07779967" }, { "nct_id": "NCT06610305", "title": "Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Transdermal estradiol", "type": "DRUG" }, { "name": "Progesterone", "type": "DRUG" }, { "name": "Transdermal placebo patch", "type": "DRUG" }, { "name": "placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 75, "start_date": "2024-09-02", "completion_date": "2028-06-01", "has_results": false, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06610305" }, { "nct_id": "NCT01301521", "title": "Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes", "Pre-Diabetes" ], "interventions": [ { "name": "water-soluble cinnamon extract (Cinnulin PF)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mike O'Callaghan Military Hospital", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 229, "start_date": "2013-06-11", "completion_date": "2019-04-26", "has_results": true, "last_update_posted_date": "2024-04-03", "last_synced_at": "2026-10-31T06:35:09.342Z", "location_count": 4, "location_summary": "Travis Air Force Base, California • Eglin Air Force Base, Florida • Offutt Air Force Base, Nebraska + 1 more", "locations": [ { "city": "Travis Air Force Base", "state": "California" }, { "city": "Eglin Air Force Base", "state": "Florida" }, { "city": "Offutt Air Force Base", "state": "Nebraska" }, { "city": "Lackland Air Force Base", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01301521" } ] }